Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

A new thesis from Karolinska Institutet aims to advance our understanding of the bidirectional relationship between ...

"The most common symptoms I hear from my patients are leg cramping or discomfort with walking. They often tell me they can ...

Lithium is associated with an increased risk for thyroid dysfunction and chronic kidney disease (CKD) in patients with incident bipolar disorder (BD), according to a study published online Feb. 11 ...

By Dani Blum The Food and Drug Administration on Tuesday approved Ozempic to reduce the risk of serious complications in people who have both Type 2 diabetes and chronic kidney disease.

People with kidney disease may be at higher risk of anxiety and depression. But taking care of your mental health can have a positive effect on your outlook with kidney disease. Chronic kidney ...

The Food and Drug Administration approved Ozempic for treating patients with chronic kidney disease on Tuesday, marking the latest authorized use for Novo Nordisk’s popular drug known for ...

Ozempic becomes the first GLP-1 treatment option for people with type 2 diabetes and chronic kidney disease The Food and Drug Administration has approved Ozempic to reduce the risk of kidney disease.

According to a 2019 review, up to 84% of people with end stage chronic kidney disease develop pruritus. The authors state that recent advancements in dialysis treatments have helped bring the ...

Efficacy was established based on the time to first occurrence of a primary composite endpoint event, defined as onset of persistent 50% or greater reduction in eGFR according to the Chronic Kidney ...

HONOLULU (KHON2) — Peripheral Artery Disease is a common condition ... And it most commonly affects people with diabetes, chronic kidney disease or smoking. It’s quite common here in Hawaii ...